Literature DB >> 17803469

Endostatin expression in the murine model of ischaemia/reperfusion-induced acute renal failure.

Maria H Bellini1, Enia L Coutinho, Thelma C Filgueiras, Thiago T Maciel, Nestor Schor.   

Abstract

BACKGROUND: Renal ischaemia-hypoxia is a leading cause of acute renal failure, a clinical condition associated with rapid loss of renal function and high rates of mortality. Renal proximal tubular cells are the most severely injured during renal ischaemia, caused by the breakdown of the extracellular matrix of the tubular basement membrane. Endostatin is the C-terminal fragment of collagen XVIII generated by proteolytic cleavage and it is well-known as being an inhibitor of angiogenesis. In vitro, endostatin inhibits endothelial cell proliferation and migration, as well as tubule formation. In vivo, it has a potent inhibitory effect on tumour growth. In this study, we analysed endostatin gene expression in C57BL/6 mouse kidneys subjected to ischaemia/reperfusion.
METHODS: Ischaemic renal failure was induced via 45 min of bilateral occlusion of the renal artery and vein, followed by 12 h or 24 h of reperfusion. Whole-kidney homogenate and total RNA were extracted for examination by western blot analysis and quantitative polymerase chain reaction. The immunohistological examination revealed increased endostatin expression in injured kidney, mainly in the proximal tubule and collecting ducts.
RESULTS: Endostatin/collagen XVIII mRNA and protein expression increased during ischaemia and within 12 h of reperfusion. In the western blot assay, we identified increased expression of the 30 kDa endostatin-related fragment and of matrix metalloproteinase-9. CD31 was significantly expressed during reperfusion (P < 0.05). Immunohistological examination revealed glomerular and tubulointerstitial expression of endostatin.
CONCLUSION: These data suggest the local synthesis of a 30 kDa endostatin-related fragment following acute renal failure and suggest its role in the modulation of renal capillary density.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17803469     DOI: 10.1111/j.1440-1797.2007.00850.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  10 in total

Review 1.  Endostatin in Renal and Cardiovascular Diseases.

Authors:  Mei Li; Zoran Popovic; Chang Chu; Bernhard K Krämer; Berthold Hocher
Journal:  Kidney Dis (Basel)       Date:  2021-09-09

2.  Differential expression of proteoglycans in tissue remodeling and lymphangiogenesis after experimental renal transplantation in rats.

Authors:  Heleen Rienstra; Kirankumar Katta; Johanna W A M Celie; Harry van Goor; Gerjan Navis; Jacob van den Born; Jan-Luuk Hillebrands
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

Review 3.  Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease.

Authors:  Yujiro Kida; Bie Nga Tchao; Ikuyo Yamaguchi
Journal:  Pediatr Nephrol       Date:  2013-03-10       Impact factor: 3.714

4.  MMP9 and SCF protect from apoptosis in acute kidney injury.

Authors:  Soraya Bengatta; Catherine Arnould; Emmanuel Letavernier; Matthieu Monge; Hélène Martinan de Préneuf; Zena Werb; Pierre Ronco; Brigitte Lelongt
Journal:  J Am Soc Nephrol       Date:  2009-04       Impact factor: 10.121

5.  Plasma endostatin predicts kidney outcomes in patients with type 2 diabetes.

Authors:  Kinsuk Chauhan; Divya Anna Verghese; Veena Rao; Lili Chan; Chirag R Parikh; Steven G Coca; Girish N Nadkarni
Journal:  Kidney Int       Date:  2018-12-24       Impact factor: 10.612

6.  Basement membrane zone collagens XV and XVIII/proteoglycans mediate leukocyte influx in renal ischemia/reperfusion.

Authors:  Azadeh Zaferani; Ditmer T Talsma; Saleh Yazdani; Johanna W A M Celie; Mari Aikio; Ritva Heljasvaara; Gerjan J Navis; Taina Pihlajaniemi; Jacob van den Born
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

7.  Validation of an enzyme-linked immunosorbent assay (ELISA) for quantification of endostatin levels in mice as a biomarker of developing glomerulonephritis.

Authors:  Jacqueline Wallwitz; Petra Aigner; Elisabeth Gadermaier; Eva Bauer; Emilio Casanova; Anton Bauer; Dagmar Stoiber
Journal:  PLoS One       Date:  2019-08-12       Impact factor: 3.240

8.  Screening plasma miRNAs as biomarkers for renal ischemia-reperfusion injury in rats.

Authors:  Jia-feng Wang; Yi-feng Zha; He-wen Li; Fei Wang; Qi Bian; Xue-li Lai; Guang Yu
Journal:  Med Sci Monit       Date:  2014-02-20

9.  Plasma endostatin may improve acute kidney injury risk prediction in critically ill patients.

Authors:  Johan Mårtensson; Niklas Jonsson; Neil J Glassford; Max Bell; Claes-Roland Martling; Rinaldo Bellomo; Anders Larsson
Journal:  Ann Intensive Care       Date:  2016-01-13       Impact factor: 6.925

10.  Derivation and validation of plasma endostatin for predicting renal recovery from acute kidney injury: a prospective validation study.

Authors:  Hui-Miao Jia; Yue Zheng; Li-Feng Huang; Xin Xin; Wen-Liang Ma; Yi-Jia Jiang; Xi Zheng; Shu-Yan Guo; Wen-Xiong Li
Journal:  Crit Care       Date:  2018-11-16       Impact factor: 9.097

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.